F 
Foremost Lithium Resource & Technology Ltd. Common stock FMST · USD
Materials · US listing · 🇺🇸 United States
0.83
+2.66%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
−$16,226
FY2017FY2026
Net income
−$4.9m
FY2017FY2026
Free cash flow
−$5.4m
FY2017FY2026
Shareholders' equity
$25.2m
FY2017FY2026
Income statement
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | −$16,226 | — | — | — | — | $574,005 | — | — | — | — |
| Gross profit | −$16,226 | — | — | −$3 | — | $574,005 | −$3,770 | — | — | — |
| Operating income | −$6.3m | −$4.1m | −$3.2m | $750,316 | −$4.0m | −$2.3m | −$2.0m | −$1.6m | −$7.0m | −$870,522 |
| Net income | −$4.9m | −$2.6m | −$3.2m | $676,772 | −$4.2m | −$2.6m | −$2.3m | −$1.9m | −$7.5m | −$893,660 |
| Diluted earnings per share | -0.30 | -0.18 | -0.36 | 0.14 | -1.03 | -0.80 | -0.83 | -0.86 | -3.61 | -0.48 |
Balance sheet
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $27.9m | $19.6m | $11.7m | $9.4m | $7.9m | $6.9m | $5.9m | $4.6m | $5.3m | $1.1m |
| Cash and short-term investments | $4.5m | $3.5m | $706,264 | $428,829 | $235,455 | $441,625 | $3,207 | $97,600 | $2.3m | $220,998 |
| Total liabilities | $2.7m | $2.3m | $2.4m | $2.1m | $1.2m | $1.2m | $867,314 | $492,591 | $658,001 | $278,817 |
| Debt | — | $368,864 | $805,495 | $913,445 | $143,840 | $197,718 | $183,700 | $3,891 | $74,641 | $4,599 |
| Shareholders' equity | $25.2m | $17.3m | $9.3m | $7.3m | $6.7m | $5.7m | $5.1m | $4.1m | $4.6m | $843,561 |
| Shares outstanding | 16m | 14m | 9m | 5m | 4m | 3m | 3m | 2m | 2m | 2m |
Cash flow
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −$5.4m | −$2.7m | −$2.7m | −$1.8m | −$992,237 | −$568,062 | −$293,306 | −$883,331 | −$1.4m | −$332,301 |
| Capital spending | −$3 | −$176,843 | −$1.8m | −$208,684 | −$155,669 | −$115,214 | −$88,437 | −$131,188 | −$239,409 | −$406,325 |
| Free cash flow | −$5.4m | −$2.9m | −$4.5m | −$2.0m | −$1.1m | −$683,276 | −$381,743 | −$1.0m | −$1.6m | −$738,626 |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | −$496,960 | — | — | — | — | — | — |
| Gross profit | — | −$496,960 | — | — | — | — | — | — |
| Operating income | −$939,043 | −$1.4m | −$1.4m | −$2.3m | −$1.2m | −$915,897 | −$1.5m | −$933,974 |
| Net income | −$731,997 | −$1.9m | −$1.4m | −$1.9m | $287,128 | $550,829 | −$1.4m | −$1.1m |
| Diluted earnings per share | -0.04 | -0.12 | -0.09 | -0.13 | 0.02 | 0.04 | -0.16 | -0.12 |
| Cash from operations | −$1.0m | −$1.0m | −$1.0m | −$1.0m | — | — | −$1.0m | — |
| Capital spending | −$1.0m | — | — | — | — | — | — | — |
| Free cash flow | −$2.0m | — | — | — | — | — | — | — |
| Total assets | $26.6m | $27.9m | $25.4m | $25.2m | $23.2m | $19.6m | $21.0m | $11.7m |
| Cash and short-term investments | $1.8m | $4.5m | $2.9m | $4.6m | $5.5m | $3.5m | $4.5m | $118,367 |
| Debt | — | — | — | $3,537 | $340,074 | $368,864 | $385,267 | $820,951 |
| Shareholders' equity | $24.8m | $25.2m | $24.4m | $23.3m | $21.1m | $17.3m | $18.5m | $8.7m |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Operating income | — | 21.8% | 47.6% |
| Net income | — | 13.4% | 43.8% |
Valuation history
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|
| Price to earnings | -2.4 | -11.9 | -3.8 | 17.9 |
| Price to sales | -734.6 | — | — | — |
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Return | 51% | -47% | -22% |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.